J3032 HCPCS code: Injection, eptinezumab-jjmr, 1 mg
J3032 is the HCPCS Level II code for injection, eptinezumab-jjmr, 1 mg. In 2024 Medicare paid an average of $13.94 per service for J3032 across 2,355,406 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 300 per day on outpatient hospital claims. Medicare volume rose 138% from 2022 to 2024 (991,105 to 2,355,406 services). In 2024, about 1,548 clinicians billed Medicare for J3032 for 3,804 beneficiaries; Florida, Texas, California accounted for 33% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2020-10-01 |
| Last action effective | 2020-10-01 |
Who bills J3032 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 1,548 |
| Medicare beneficiaries | 3,804 |
| States with claims | 37 |
| Share of services in top 3 states (Florida, Texas, California) | 33% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J3032, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 991,105 | 2,045 | $15.52 | $12.36 |
| 2023 | 1,634,457 | 2,951 | $16.32 | $12.98 |
| 2024 | 2,355,406 | 3,804 | $17.51 | $13.94 |
States with the most J3032 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 328,101 | $14.17 |
| Texas | 233,012 | $13.89 |
| California | 209,009 | $14.23 |
| Georgia | 137,501 | $14.06 |
| New York | 123,503 | $13.17 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 300 | Prescribing Information |
| practitioner claims | 300 | Prescribing Information |
What changed for J3032
- 2020-10-01: J3032 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J3032?
J3032 is the HCPCS Level II code for injection, eptinezumab-jjmr, 1 mg. Short descriptor: "Inj. eptinezumab-jjmr 1 mg".
How much does Medicare pay for J3032?
In 2024, the average Medicare payment was $13.94 per service (average allowed $17.51).
Does Medicare cover J3032?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J3032 can be billed per day?
300 on outpatient hospital claims; 300 on practitioner claims (NCCI medically unlikely edits).
Related J30 codes
- J3000 — Injection, streptomycin, up to 1 gm
- J3010 — Injection, fentanyl citrate, 0.1 mg
- J3030 — Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J3031 — Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
- J3055 — Injection, talquetamab-tgvs, 0.25 mg
- J3060 — Injection, taliglucerase alfa, 10 units
- J3070 — Injection, pentazocine, 30 mg
- J3090 — Injection, tedizolid phosphate, 1 mg
- J3095 — Injection, telavancin, 10 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J3032
- Watch J3032 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J3032
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.